Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 10.7x - 11.8x | 11.3x |
Historical Pb Multiple | 0.8x - 6.2x | 3.6x |
Fair Value | ₹277.89 - ₹307.14 | ₹292.52 |
Upside | -28.4% - -20.9% | -24.6% |
Benchmarks | - | Full Ticker |
Maitreya Medicare Limited | - | NSEI:MAITREYA |
Mono Pharmacare Limited | - | NSEI:MONOPHARMA |
Family Care Hospitals Limited | 51,611,000.0% | BSE:516110 |
Aashka Hospitals Limited | 54,334,600.0% | BSE:543346 |
QMS Medical Allied Services Limited | - | NSEI:QMSMEDI |
One Global Service Provider Limited | 51,433,000.0% | BSE:514330 |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
MAITREYA | MONOPHARMA | 516110 | 543346 | QMSMEDI | 514330 | |||
NSEI:MAITREYA | NSEI:MONOPHARMA | BSE:516110 | BSE:543346 | NSEI:QMSMEDI | BSE:514330 | |||
Historical Net Income Growth | ||||||||
5Y CAGR | NM- | NM- | 266.1% | 11.6% | 24.3% | 92.7% | ||
3Y CAGR | -12.8% | 195.0% | 45.5% | -16.9% | -6.2% | 45.0% | ||
Latest Twelve Months | NM | 29.6% | -793.7% | 312.4% | 13.9% | 220.5% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 7.3% | 1.9% | -10.3% | -0.9% | 7.6% | -2155.3% | ||
Prior Fiscal Year | 8.5% | 2.8% | 12.5% | -13.6% | 6.1% | 7.6% | ||
Latest Fiscal Year | 5.9% | 2.0% | 31.4% | 10.3% | 7.4% | 11.3% | ||
Latest Twelve Months | 4.3% | 2.0% | -301.5% | 14.5% | 7.2% | 12.7% | ||
Return on Equity | ||||||||
5 Year Average Margin | 18.9% | 8.0% | 20.1% | -0.3% | 21.8% | 37.0% | ||
Prior Fiscal Year | 38.4% | 6.9% | 17.5% | -2.7% | 12.6% | 20.9% | ||
Latest Twelve Months | 9.4% | 9.9% | -116.3% | 3.7% | 12.2% | 83.8% | ||
Next Fiscal Year | 14.5% | 36.5% | 21.7% | 2.4% | 13.5% | 80.8% | ||
Two Fiscal Years Forward | 14.6% | 52.7% | 17.8% | 2.9% | 13.6% | 74.0% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | 4.4x | 0.3x | 1.6x | 9.8x | 0.9x | 2.9x | ||
Price / LTM EPS | 102.1x | 14.2x | -0.5x | 67.3x | 13.0x | 22.9x | ||
Price / Book | 6.5x | 1.3x | 1.3x | 2.4x | 1.6x | 14.3x | ||
Price / Fwd Book | 7.5x | 1.0x | 0.3x | 2.4x | 1.8x | 8.1x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | 1.3x | 1.6x | 6.5x | |||||
Historical P/B Ratio | 0.8x | 3.6x | 6.2x | |||||
Selected P/B Multiple | 10.7x | 11.3x | 11.8x | |||||
(x) Book Value | 184 | 184 | 184 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | MAITREYA | MONOPHARMA | 516110 | 543346 | QMSMEDI | 514330 | |
Value of Common Equity | 2,154 | 406 | 226 | 2,389 | 1,589 | 2,758 | |
(/) Shares Outstanding | 6.8 | 17.7 | 54.0 | 23.4 | 17.9 | 7.1 | |
Implied Stock Price | 317.90 | 23.00 | 4.18 | 102.10 | 89.00 | 388.20 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 317.90 | 23.00 | 4.18 | 102.10 | 89.00 | 388.20 | |
Trading Currency | INR | INR | INR | INR | INR | INR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |